Indonesia Investments Report - January 2021 Edition: COVID-19 Crisis to Linger On?
Update COVID-19 in Indonesia: 1,298,608 confirmed infections, 35,014 deaths (23 February 2021)
23 February 2021 (closed)
USD/IDR (14,146) -6.00 -0.04%
EUR/IDR (17,335) +57.05 +0.33%
Jakarta Composite Index (6,272.81) +17.50 +0.28%
Indofarma
PT Indofarma Tbk is an Indonesian state-controlled pharmaceutical company.
Profile
| Industry Sector | Consumer Goods Industry |
| Industry Sub Sector | Pharmaceuticals |
| Established | 2 January 1996 |
| Listed | 17 April 2001 |
| Listed Company Code | INAF |
| Listed Shares | 3,099,267,500 |
| Dividend | No |
| Major Shareholders (>5%) | Government of Indonesia (80.66%) |
| Key Subsidiaries | Indofarma Global Medika |
Stock Quote Indofarma - INAF:
Location
Contact Details
Jalan Indofarma No. 1
West Cikarang
Bekasi - 17530
Phone: +62 21 8832 3975
Fax: +62 21 8832 3972
Email: general@indofarma.co.id
www.indofarmagroup.com